Eli Lilly antibody trial paused due to potential safety concern
Oct 13 (Reuters) - U.S. drugmaker Eli Lilly and Co said on Tuesday that the government-sponsored clinical trial of its COVID-19 antibody treatment has been...
Oct 13 (Reuters) - U.S. drugmaker Eli Lilly and Co said on Tuesday that the government-sponsored clinical trial of its COVID-19 antibody treatment has been...